Impact of including productivity costs in economic analyses of vaccines for C. difficile infections and infant respiratory syncytial virus, in a UK setting

It has been estimated that vaccines can accrue a relatively large part of their value from patient and carer productivity. Yet, productivity value is not commonly or consistently considered in health economic ...

Source: Cost Effectiveness and Resource Allocation - April 30, 2024 Category: Health Management Authors: Margherita Neri, Janne C. Mewes, Fernando Albuquerque de Almeida, Sophia Stoychev, Nadia Minarovic, Apostolos Charos, Kimberly M. Shea and Lotte M.G. Steuten Tags: Research Source Type: research